Arovella Therapeutics (STU:E4NA) Days Inventory: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Arovella Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Arovella Therapeutics's Average Total Inventories for the six months ended in Jun. 2026 was €0.00 Mil. Arovella Therapeutics's Cost of Goods Sold for the six months ended in Jun. 2026 was €0.04 Mil. Hence, Arovella Therapeutics's Days Inventory for the six months ended in Jun. 2026 was 0.00.

The historical rank and industry rank for Arovella Therapeutics's Days Inventory or its related term are showing as below:

During the past 13 years, Arovella Therapeutics's highest Days Inventory was 1186.25. The lowest was 72.34. And the median was 111.16.

STU:E4NA's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 184.66
* Ranked among companies with meaningful Days Inventory only.

Arovella Therapeutics's Days Inventory stayed the same from Jun. 2025 () to Jun. 2026 ().

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Arovella Therapeutics  (STU:E4NA) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Arovella Therapeutics's Inventory Turnover for the six months ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.035266827460092 / 0
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Arovella Therapeutics's Inventory to Revenue for the six months ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Arovella Therapeutics Days Inventory Related Terms

Arovella Therapeutics Days Inventory Historical Data

* Premium members only.

The historical data trend for Arovella Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arovella Therapeutics Days Inventory Chart

Arovella Therapeutics Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Arovella Therapeutics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:E4NA vs VRTX, REGN, MRNA: Days Inventory Comparison

For the Biotechnology subindustry, Arovella Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arovella Therapeutics Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arovella Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Arovella Therapeutics's Days Inventory falls into.


Arovella Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Arovella Therapeutics's Days Inventory for the fiscal year that ended in Jun. 2026 is calculated as

Days Inventory (A: Jun. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Jun. 2025 ) + Total Inventories (A: Jun. 2026 )) / count ) / Cost of Goods Sold (A: Jun. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0.068383925558954*365
=0 / 0.068383925558954*365
=0.00

Arovella Therapeutics's Days Inventory for the quarter that ended in Jun. 2026 is calculated as:

Days Inventory (Q: Jun. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Jun. 2026 )) / count ) / Cost of Goods Sold (Q: Jun. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 0.035266827460092*365 / 2
=0 / 0.035266827460092*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arovella Therapeutics Business Description

Other Exchanges E4NA:GermanyALA:Australia
Address 84 Hotham Street, Corporate One, Preston, VIC, AUS, 3072
Arovella Therapeutics Ltd is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours. The company's lead iNKT cell product is ALA-101. ALA-101 consists of iNKT cells engineered to produce a Chimeric Antigen Receptor (CAR) targeting CD19 on their surface. This CD19-targeting CAR allows the iNKT cells to find and kill tumour cells that express CD19.